Market Cap 101.27M
Revenue (ttm) 3.55M
Net Income (ttm) -14.88M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -419.15%
Debt to Equity Ratio 0.00
Volume 65,768
Avg Vol 248,472
Day's Range N/A - N/A
Shares Out 20.92M
Stochastic %K 77%
Beta 0.27
Analysts Strong Sell
Price Target $16.07

Company Profile

Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary therapies to enhance the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It develops COYA 302, a biologic combination for subcutaneous administration intended to enhance Treg function while depleting T effector function and activated macrophages in Phase...

Industry: Biotechnology
Sector: Healthcare
Phone: 800 587 8170
Address:
5850 San Felipe St., Suite 500, Houston, United States
Cinderblocks
Cinderblocks Feb. 9 at 6:37 PM
$COYA Strange. Starts of strong every day and looks like it will break through 5 resistance and then just tapers off. Been like this since I bought in heh. Inflows are usually beating outflows.
0 · Reply
Jwa68
Jwa68 Feb. 7 at 4:47 PM
$COYA Most who have followed me know that I often bet on the jockey. Management is always the key. In the case of COYA, I own over 150K shares, I wish it were far more. My investment is predicated on two things, data and how I feel personally about CEO Arun and his team. This is a man with a track record of deal making, well regarded by all who know him. He has impeccable character, integrity, fundamentally understanding and living up to his responsibility to shareholders. He recently wrote the following to all of us and it was both insightful and telling. "Our management team and board of directors are considerable shareholders along with you, aligning our collective interests. We only win if you win. We are deeply grateful to our employees, investigators, clinical partners, and—most importantly—the patients and families who make our work possible. We look forward to updating you on our continued progress throughout the year." I fully expect his words to have been prophetic.
0 · Reply
zampy
zampy Feb. 7 at 1:52 PM
$COYA This will be over $5 this week... 100% positive.....
0 · Reply
Jwa68
Jwa68 Feb. 6 at 7:32 PM
$COYA Deep value and just incredible asymmetric risk in my mind. Target $20.
0 · Reply
LibertarianTreehugger
LibertarianTreehugger Feb. 6 at 5:42 PM
Coya Therapeutics Raises $11M to Support New ALS Therapy: https://jlsfund.substack.com/p/coya-therapeutics-raises-11m-to-support $COYA
0 · Reply
zampy
zampy Feb. 6 at 3:20 PM
$COYA The buyer at 1.60 1.61 600k seems to be buying here...
1 · Reply
zampy
zampy Feb. 6 at 3:18 PM
$COYA GOLDMAN SACHS at $1.72...accumulating...on bid 1.66
0 · Reply
kornlover
kornlover Feb. 5 at 12:57 PM
$COYA 2/3 update on clinical trials site. Now only 1 US site not yet recruiting while 1 of 4 Canadian sites now recruiting.
0 · Reply
NVDAMillionaire
NVDAMillionaire Feb. 4 at 1:14 PM
$COYA Excellent article that nails exactly where COYA stands right now. So if you want to update your COYA knowledge or get acquainted with COYA, this is a must read. https://everyticker.com/quote/COYA/analysis/coya-therapeutics-unlocking-treg-potential-in-neurodegenerative-disease-nasdaq-coya
1 · Reply
Jwa68
Jwa68 Feb. 4 at 1:11 PM
$COYA Still cannot rationalize the cutrent sub $5 price. I expect the opportunity is fleeting.
1 · Reply
Latest News on COYA
Coya Therapeutics Announces $11.1 Million Private Placement

Jan 30, 2026, 8:00 AM EST - 10 days ago

Coya Therapeutics Announces $11.1 Million Private Placement


Coya Therapeutics Now Pivots Toward Phase 2 In ALS And FTD

Feb 7, 2025, 5:17 PM EST - 1 year ago

Coya Therapeutics Now Pivots Toward Phase 2 In ALS And FTD


Coya Therapeutics: Buying The Dip After Unwarranted Sell-Off

Oct 31, 2024, 10:31 AM EDT - 1 year ago

Coya Therapeutics: Buying The Dip After Unwarranted Sell-Off


Cinderblocks
Cinderblocks Feb. 9 at 6:37 PM
$COYA Strange. Starts of strong every day and looks like it will break through 5 resistance and then just tapers off. Been like this since I bought in heh. Inflows are usually beating outflows.
0 · Reply
Jwa68
Jwa68 Feb. 7 at 4:47 PM
$COYA Most who have followed me know that I often bet on the jockey. Management is always the key. In the case of COYA, I own over 150K shares, I wish it were far more. My investment is predicated on two things, data and how I feel personally about CEO Arun and his team. This is a man with a track record of deal making, well regarded by all who know him. He has impeccable character, integrity, fundamentally understanding and living up to his responsibility to shareholders. He recently wrote the following to all of us and it was both insightful and telling. "Our management team and board of directors are considerable shareholders along with you, aligning our collective interests. We only win if you win. We are deeply grateful to our employees, investigators, clinical partners, and—most importantly—the patients and families who make our work possible. We look forward to updating you on our continued progress throughout the year." I fully expect his words to have been prophetic.
0 · Reply
zampy
zampy Feb. 7 at 1:52 PM
$COYA This will be over $5 this week... 100% positive.....
0 · Reply
Jwa68
Jwa68 Feb. 6 at 7:32 PM
$COYA Deep value and just incredible asymmetric risk in my mind. Target $20.
0 · Reply
LibertarianTreehugger
LibertarianTreehugger Feb. 6 at 5:42 PM
Coya Therapeutics Raises $11M to Support New ALS Therapy: https://jlsfund.substack.com/p/coya-therapeutics-raises-11m-to-support $COYA
0 · Reply
zampy
zampy Feb. 6 at 3:20 PM
$COYA The buyer at 1.60 1.61 600k seems to be buying here...
1 · Reply
zampy
zampy Feb. 6 at 3:18 PM
$COYA GOLDMAN SACHS at $1.72...accumulating...on bid 1.66
0 · Reply
kornlover
kornlover Feb. 5 at 12:57 PM
$COYA 2/3 update on clinical trials site. Now only 1 US site not yet recruiting while 1 of 4 Canadian sites now recruiting.
0 · Reply
NVDAMillionaire
NVDAMillionaire Feb. 4 at 1:14 PM
$COYA Excellent article that nails exactly where COYA stands right now. So if you want to update your COYA knowledge or get acquainted with COYA, this is a must read. https://everyticker.com/quote/COYA/analysis/coya-therapeutics-unlocking-treg-potential-in-neurodegenerative-disease-nasdaq-coya
1 · Reply
Jwa68
Jwa68 Feb. 4 at 1:11 PM
$COYA Still cannot rationalize the cutrent sub $5 price. I expect the opportunity is fleeting.
1 · Reply
DB32022
DB32022 Feb. 4 at 12:54 PM
$COYA is there any word on the Nfl data? I don’t see it on the latest investor presentation
1 · Reply
EmotionlessRobot
EmotionlessRobot Feb. 4 at 12:09 PM
$COYA Missed this. Insider Activity (Form 4): CEO Dr. Arun Swaminathan was granted 293,983 stock options on January 22, with an exercise price of $4.73. CFO David Snyder was granted 140,041 stock options at the same price. Director Wilbur Ross Jr. received a grant of 10,000 options on January 2 at 5.65
1 · Reply
foreverboner
foreverboner Feb. 4 at 1:41 AM
$COYA Interview with Arun (third video scrolling down) https://www.insideprecisionmedicine.com/topics/translational-research/pills-electrodes-viruses-and-tregs-growing-medicines-toolbox/
0 · Reply
Jwa68
Jwa68 Feb. 3 at 11:02 PM
$COYA Nice accumulation occuring.
0 · Reply
Robby83
Robby83 Feb. 3 at 9:34 PM
$COYA and here I am thinking I was going to get some cheap shares this week 🙃
0 · Reply
Jwa68
Jwa68 Feb. 3 at 3:26 AM
$COYA DRL Chair says “next phase of growth must come from higher value science-led therapies"
0 · Reply
irf944
irf944 Feb. 2 at 5:33 PM
$COYA Confident as ever after Dr. Reddy invested $11M last week. Dr. Reddy is the most intimate with the science and data, and their most recent investment confirms their confidence in Coya and their progress. Everything is aligning....zero debt, plenty of cash and runway, FDA acceptance of IND, Buy ratings, and Dr. Reddy's (and Einhorn's) recent investments. Can't imagine that many shares being available with a float of 19M shares. Will not take much for SP to climb back up with low float. Some patience should be nicely rewarded.
1 · Reply
zampy
zampy Feb. 2 at 3:58 PM
$COYA 50 cents down ...$15 to $20 up.....Right people are involved..Stopping 2 indications in ALS and FTD is a major scientific breakthrough. I believe in 2026 this will be 400% to 500% higher. In it ti win it.
0 · Reply
Jwa68
Jwa68 Feb. 2 at 3:04 PM
0 · Reply
zampy
zampy Feb. 2 at 2:03 PM
$COYA Wainwright reiterates $18 twelve month target
0 · Reply
zampy
zampy Feb. 1 at 11:48 AM
$COYA Vanguard up to 891k shares over 4.26%.
0 · Reply
zampy
zampy Jan. 31 at 2:10 PM
$COYA Vanguard increased their holdings to 891k shares.
0 · Reply